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Abstract:  Primary care practitioners are ideally situated
to carry out health promotion activities.  Neural tube
defects are of a fairly low incidence, but the consequences
are tragic.  They range from life long physical and often
intellectual disabilities, to death at birth.  Increased folate
intake, either through eating folate rich foods or through
supplementation, has been shown to reduce the incidence
of neural tube defects in newborns by up to 75%.
Encouraging all women of child-bearing age to increase
their folate intake could thus prevent a significant number
of neural tube defects occurring in the Australian
population.
Key Indexing Terms:  Primary health care, neural tube
defects, folate.
INTRODUCTION
Primary care practitioners see a variety of people from all
age groups and all backgrounds, and are ideally placed to
carry out opportunistic health promotion programs.  The
chiropractor or osteopath can use their general health
knowledge, as well as their manual therapy skills, to
improve the health profile of those patients who attend for
treatment.
Neural tube defects are a group of congenital anomalies
that include anencephaly, spina bifida and encephalocoele.
They are all characterised by abnormal development of
the neural tube (the precursor of the spinal cord) during
early embryonic life, usually accompanied by defects of
the vertebral column or skull.  In normal development a
plaque of nerve tissue forms along the surface of what will
become the back of the foetus.  This tissue folds into a
closed tube that develops into the structures of the central
nervous system.  Malformations occur either because the
tube fails to close properly, because parts of it are missing,
or because part of the tube is blocked.
Children born with anencephaly, which is a lack of part
or whole of the brain and cranium, are stillborn or die
soon after birth. Encephalocele occurs when a meningeal
sac containing brain tissue protrudes from the skull, and
the outlook for affected individuals depends upon the
amount of nervous tissue involved.  Spina bifida and
other abnormalities of closure of the vertebral arches,
result when part of the spinal cord is left uncovered by the
skin, or actually protrudes from the spinal column.
Children born with the more serious forms of spina bifida
experience paralysis in those parts of the body below the
site involved.  The legs may be completely paralysed, and
bladder and bowel functions may be absent or impaired
(1).
Incidence of Neural Tube Defects
The overall rate of neural tube defects for all of Australia
has been estimated at 1.9 per thousand births (2).  Over
95% of pregnancies with neural tube defects occur in
women without a previous affected pregnancy (3).  Women
who have had a previous pregnancy with a neural tube
defect have a significantly increased risk of recurrence, in
the order of 40-50 per thousand births.
Association between Folate and Neural Tube Defects
Folate, or folic acid, is a vitamin of the B complex.  In
humans, folate is necessary for the synthesis of nucleic
acids and the formation of red blood cells. Its major
sources in the human diet include green leafy vegetables,
whole grains and legumes.  The recommended daily
allowance of folate is 500mg per day.
There is increasing evidence that periconceptional folate
has a role in the formation of neural tube defects.  Although
the mechanism is not known, increased consumption of
folate through diet or supplementation before and during
pregnancy reduces the number of neural tube defect
affected pregnancies.  Between 1980 and 1995, fourteen
human studies of varied design have collectively
demonstrated that increased intake of folate at the start of
pregnancy can reduce the incidence of neural tube defects
by about 75% (4).  The evidence from two of these studies
is unequivocal, with two randomised controlled trials
showing a decreased incidence of neural tube defects in
both previously affected and unaffected pregnancies (3,5).
Previous and subsequent studies are confirmatory of this
result (6,7,8).  These studies have shown a protective
effect of either dietary folate or supplementary folic acid.
Only one study published has failed to show a relationship
between periconceptional folate and neural tube defects
(9).  This paper was a case control study and has been
superseded by the more recent, and experimentally
stronger, randomised control trials.
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There is also some evidence that the use of folate can
benefit the health of the general population, as well as
women of child-bearing age.  It has recently been suggested
that folate may reduce the risk of cardiovascular disease
(10), and may also have a role in the protection against
colon, uterine and cervical cancers (11).
Problems with the Use of Folate
The use of folate supplementation is not known to cause
any significant problems.  Folate is not known to be toxic.
Even in large doses, folic acid has not been shown to
cause harm (12).  There are, however, two areas of
concern.  The first is that the use of folic acid may
complicate the diagnosis of vitamin B12 deficiency in
certain people (13).  Folic acid intake may mask the
anaemia that accompanies the irreversible damage that
occurs due to a deficiency of vitamin B12.  However,
vitamin B12 deficiency disease of the nervous system is
not diagnosed any longer by waiting for anaemia to occur.
Primary care practitioners are trained to recognise the
syndromes that could be due to vitamin B12 neuropathy,
such as peripheral nerve damage, and therefore to send
off for plasma levels of vitamin B12 before significant
damage could occur (14).  The second concern is that folic
acid may interfere with epilepsy medication (12).  This is
only relevant when taking high doses of folic acid, and
may therefore be monitored closely in such patients.  In
general, however, data suggesting that folic acid
supplementation is unsafe, are weak and consist
predominantly of case series and reports (15).
A recent article in the Lancet (16) contemplates recent
findings from the original Czeizel and Dudas (5) study
that suggests an increased rate of abortion in women who
take folic acid supplementation.  The authors concluded
that the benefit of reducing neural tube defects far
outweighed the dangers.  They also suggested that the
findings might actually be due to folic acid being able to
assist in terathanasia, in that the mother selectively
aborts affected foetuses.  Thus, folic acid may prevent
some defects indirectly through terathanasia, and directly
by inhibiting the formation of neural tube defects.
Awareness of the Folate and Neural Tube Defect
Association in Women
Knowledge in the community of the relationship between
folate and neural tube defects is low.  Two studies found
in the literature reported on this.  The Morbidity and
Mortality Weekly Review (17) reported on a telephone
survey of reproductive-aged women.  The study found
that 71% of the women surveyed did not know that folic
acid can prevent some birth defects, and only 20%
consumed a multivitamin containing adequate amounts
of folate per day.  A study conducted in Western Australia,
as part of a health promotion program, surveyed women
of child-bearing age to determine their knowledge of
folate and spina bifida (18).  Only 8.2% of the women
surveyed stated the correct association between folate and
spina bifida.  These studies highlight the need for education
of women of child-bearing age to increase the awareness
of the association between folate and neural tube defects.
Knowledge is the first step in changing a community’s
behaviour.
Health Promotion
Health promotion aimed at women who are planning a
pregnancy would be imperative in the reduction of neural
tube defect affected pregnancies.  However, in Australia
a large proportion of pregnancies are unplanned (19),
and women would therefore not necessarily be aware of
the protective effect of folate before they became pregnant.
The human neural tube normally closes by the end of the
third week after conception, and thus any influence
affecting the closure of the neural tube must be present
before this occurs.  These two facts stress the need that
education from a primary care practitioner must be aimed
at all women of child-bearing age to be effective.
The table indicates from which foods folate is readily
obtainable.  Encouraging all women of child-bearing age
to increase their folate intake must involve practical and
simple steps to ensure compliance.  Eating foods rich in
folate, or the supplementation of 500mg of folate daily,
would adequately meet the need to reduce the chance of
a neural tube defect pregnancy.  Women who have
Excellent food choices 50-80 µg per serve
Asparagus 3 spears
Brussel sprouts, steamed ½ cup
Dried beans/chick peas, boiled ½ cup
Endive lettuce ½ cup
Liver, chicken 100g
Vegemite/marmite 1 teaspoon
Very good food choices 25-50 µg per serve
Broccoli/cauliflower ½ cup
Green beans/peas, steamed ½ cup
Oranges/orange juice 1 fruit
Porridge ½ cup
Potato 100g
Wheatgerm, wheat bran 2 tablespoons
Wholegrain bread 2 slices
Good food choices 10-25 µg per serve
Bananas 1 medium fruit
Nuts: almonds, cashews, hazelnuts, peanuts 30g
Tomato ½ fruit
Salmon, tinned 100g
*Table adapted from a pamphlet produced by the New South Wales Health 
Department.
Table:  Foods rich in folate*.  To obtain the adequate amount of folate per 
day requires 2 serves of these fruits, 5 serves of these vegetables and 7 
serves of bread and cereal.
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previously had an affected pregnancy, or have a close
family history of neural tube defects, should take a
supplement of 5mg of folate daily for at least one month
before, and for the first three months of pregnancy.
Taking folate in such large doses should not be obtained
from multivitamin tablets because the intake of other
vitamins, especially vitamin A, would then be too high.
CONCLUSION
Chiropractors, osteopaths and other primary health care
practitioners have a responsibility to pass on the findings
of scientific research to their patients.  This is especially
true in the case of women consuming adequate amounts
of folate before attempting to become pregnant.  Research
has shown unequivocally that an increased intake of
folate before conception reduces the incidence of neural
tube defects.  For women who have had a previously
affected pregnancy this is even more essential.  When
encouraging an increase in folate intake, practitioners
should be aware of any potential problems that may arise.
Practitioners should carefully monitor any women at an
increased risk of vitamin B12 deficiency, such as vegans,
for any signs and symptoms of neurological damage at
any time, but even more so when consuming extra folate.
Women who are taking epileptic medication should take
folate supplementation with care, as folate may interfere
with the absorption of the medication.
A reduction in the incidence of neural tube defects in the
newborn would lead to improved social, emotional and
financial consequences for the community in general,
and the reduction of unnecessary heartache and cost to
the families potentially involved.
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